Chrysler 2014 Annual Report Download - page 171

2014 | ANNUAL REPORT 169
As a result of new product strategies, the streamlining of architectures and related production platforms associated
with the Group’s refocused product strategies, the operations to which specific capitalized development costs
belonged was redesigned. For example, certain models were switched to new platforms considered technologically
more appropriate. As no future economic benefits were expected from these specific capitalized development costs,
they were written off in accordance with IAS 38 - Intangible Assets. For the year ended December 31, 2014, specific
capitalized development costs of €47 million within the EMEA segment and €28 million of development costs within
the NAFTA segment were written off and recorded within Research and development costs in the Consolidated
income statement. In addition, in 2014, the Group recorded €25 million of impairment losses primarily related to
the EMEA segment for certain powertrains that were abandoned. For the year ended December 31, 2013, specific
capitalized development costs of €65 million within the Maserati segment, €90 million within the EMEA segment and
€32 million of development costs within the LATAM segment were written off.
The following table sets forth all impairment charges recognized for non-current assets with definite useful lives during
the years ended December 31, 2014, 2013 and 2012.
Impairments to Property, plant and equipment:
Twelve Months Ended December 31,
2014 2013 2012
Note (€ million)
EMEA 25 55 40
Components 231 8
LATAM —— 1
Other 6— 1
(15) 33 86 50
Recorded in the Consolidated income statement within:
Cost of sales 33 — 50
Other unusual expenses —86 —
33 86 50
Impairments to Other intangible assets:
Twelve Months Ended December 31,
2014 2013 2012
Note (€ million)
Development costs
EMEA 47 151 33
NAFTA 28 — —
Components 32 21
Maserati —65 —
LATAM —32 2
APAC 4— 1
82 250 57
Other intangible assets —— 1
(14) 82 250 58
Recorded in the Consolidated income statement within:
Cost of sales —— 1
Research and development costs 82 24 57
Other unusual expenses —226 —
82 250 58